LLF-KY (6666) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 羅麗芬-KY

LLF-KY (6666) reported revenue of NT$78.3 million for Oct 2026, +16.6% year on year and +1.3% from the previous month. Revenue for Jan–Oct 2026 was NT$998.2 million (+8.4% year on year).

In Oct 2026, it ranked No. 87 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$70 million24/10Nov 2024 NT$64.5 millionDec 2024 NT$104.1 millionJan 2025 NT$61.9 millionFeb 2025 NT$66.7 million25/02Mar 2025 NT$119.5 millionApr 2025 NT$102 millionMay 2025 NT$116.6 millionJun 2025 NT$129.5 million25/06Jul 2025 NT$84.1 millionAug 2025 NT$69.5 millionSep 2025 NT$103.7 millionOct 2025 NT$67.1 million25/10Nov 2025 NT$74 millionDec 2025 NT$118.2 millionJan 2026 NT$67.4 millionFeb 2026 NT$58.4 million26/02Mar 2026 NT$101.8 millionApr 2026 NT$114.5 millionMay 2026 NT$157.6 millionJun 2026 NT$167.8 million26/06Jul 2026 NT$94.6 millionAug 2026 NT$80.6 millionSep 2026 NT$77.3 millionOct 2026 NT$78.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$78.3 million+16.6%+1.3%
Sep 2026NT$77.3 million-25.5%-4.1%
Aug 2026NT$80.6 million+15.9%-14.9%
Jul 2026NT$94.6 million+12.5%-43.6%
Jun 2026NT$167.8 million+29.5%+6.4%
May 2026NT$157.6 million+35.1%+37.7%
Apr 2026NT$114.5 million+12.2%+12.5%
Mar 2026NT$101.8 million-14.8%+74.2%
Feb 2026NT$58.4 million-12.5%-13.4%
Jan 2026NT$67.4 million+8.9%-42.9%
Dec 2025NT$118.2 million+13.6%+59.7%
Nov 2025NT$74 million+14.7%+10.3%
Oct 2025NT$67.1 million-4.1%-35.3%
Sep 2025NT$103.7 million-4.7%+49.1%
Aug 2025NT$69.5 million-31.2%-17.3%
Jul 2025NT$84.1 million-4.9%-35.1%
Jun 2025NT$129.5 million-1.0%+11.1%
May 2025NT$116.6 million+4.5%+14.4%
Apr 2025NT$102 million-5.9%-14.6%
Mar 2025NT$119.5 million+10.2%+79.0%
Feb 2025NT$66.7 million-9.4%+7.8%
Jan 2025NT$61.9 million+9.6%-40.5%
Dec 2024NT$104.1 million-0.2%+61.2%
Nov 2024NT$64.5 million-23.4%-7.8%
Oct 2024NT$70 million+28.6%-35.7%

Jan–Oct 2026 cumulative: NT$998.2 million (+8.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: LLF-KY vs PEC / LLF-KY vs Lotus Pharm / LLF-KY vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16